Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272192 · ClinicalTrials.gov registry record · NA
Intervention Effects of Intensity and Delivery Style for Toddlers With Autism
A NA study of Autism Spectrum Disorder, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 3
- Study locations
NCT02272192: Completed NA study of Autism Spectrum Disorder, sponsored by University of California, Davis.
NCT02272192 is a NA study of Autism Spectrum Disorder that has completed, run by University of California, Davis. The registered enrollment target is 87 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (36% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272192, a NA study of Autism Spectrum Disorder, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 3
- Study locations
Study Summary
A multi-site randomized study of intensive treatment for toddlers with autism involving a three-site collaborative network plus a data coordinating center to evaluate the effects of intervention intensity and intervention style delivered for 12 months, on the progress of very young children with ASD ages 12-30 months old and their families, and the effect of children's developmental rates and autism severity on their response to intervention.
Primary Outcome
We used Time 4 means and standard deviations (SDs)s from several measures to compute a z score. The mean of a Z score is always 0 and z scores range from -3 to +3. For this composite a higher score reveals more mature developmental skills. Data from the following measures were used in this composite score: a weighted frequency of intentional communication measured within a 15 minute communication sample; number of different root words measured within the communication sample; the expressive lang
Conditions Studied
Interventions
- BEHAVIORAL Early Start Denver Model (ESDM)
- BEHAVIORAL Early Intensive Behavioral Intervention (EIBI)
Study Locations (3)
California
- UC Davis MIND Institute - Sacramento
Tennessee
- Vanderbilt University - Nashville
Washington
- University of Washington Autism Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
What the finished NCT02272192 record still lists
NCT02272192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Early Start Denver Model (ESDM) is the first listed.
NCT02272192 reports a single indexed study location in California, Tennessee, Washington.
Frequently Asked Questions
What is clinical trial NCT02272192 about?
NCT02272192 is a clinical study titled "Intervention Effects of Intensity and Delivery Style for Toddlers With Autism". A multi-site randomized study of intensive treatment for toddlers with autism involving a three-site collaborative network plus a data coordinating center to evaluate the effects of intervention intensity and intervention style delivered for 12 months, on the progress of very young children with ASD...
What is the current status of trial NCT02272192?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2013-03. Estimated completion is 2019-07-01.
What conditions does trial NCT02272192 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT02272192?
The interventions under investigation include: Early Start Denver Model (ESDM) (BEHAVIORAL), Early Intensive Behavioral Intervention (EIBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02272192?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02272192 being conducted?
This trial has 3 study locations across California, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02272192's enrollment target sits among peer trials
87 86th of 224 higher than 139 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia